• Skip to main content
  • Skip to footer

Sun Health Center

We help your mind function at peak performance, to experience a happier, healthier and high-achieving life.

855-459-0278
  • About Us
    • Dr. Dogris
    • Our Staff
    • Our Facilities
    • Book an Appointment
    • Contact Us
  • Neuro Therapy
    • Peak Performance
    • Mental Health Issues
    • Traumatic Brain Injury
    • Addiction Treatment Services
  • Our Services
    • Adolescents
    • TMS Therapy
    • IV Therapy
      • IV Ketamine Therapy
      • IV Vitamin Infusions
    • MAT
      • Suboxone Maintenance
      • Vivitrol
  • First Responders & Veterans
  • Blog

qEEG-Guided Care: How Brain Mapping Decides Your Treatment Plan

Nov 20, 2026 by Sunhealth

How qEEgs are Used for therapy

Two people can have the same depression diagnosis yet respond very differently to treatment. One might benefit from transcranial magnetic stimulation (TMS), while another may need a different approach. Understanding these differences is one reason Sun Health Center uses brain mapping as part of the assessment process.

qEEG-guided treatment starts with understanding a patient’s brain activity before considering options such as TMS, ketamine and neurofeedback. The results don’t automatically determine which therapy someone receives. Instead, they provide additional information that our clinicians use alongside medical history, symptoms and psychiatric assessments to develop a personalized plan.

What a qEEG Brain Map Measures

A quantitative electroencephalogram (qEEG) is a noninvasive assessment that records electrical activity through sensors placed on the scalp.

The recording is processed to examine patterns such as the distribution and relative strength of different brainwave frequencies. Clinicians can review these findings for features that may be relevant to a patient’s symptoms and treatment goals.

For example, a brain map may reveal differences in the activity of certain frequency bands or how electrical activity is distributed across the scalp. These measurements provide information about brain function, but they don’t identify a specific mental health condition on their own.

Traditional mental health assessments rely heavily on reported symptoms, medical history and clinical interviews. These remain essential, but qEEG introduces another perspective by measuring aspects of brain function directly.

The value of collecting this information early is that clinicians have a baseline to consider before recommending treatment or evaluating changes over time.

From Map to Plan: How Results Guide Treatment

Once the qEEG recording is complete, our clinicians review the findings alongside the patient’s psychiatric evaluation, symptoms, medication history and previous treatment responses. This helps build a fuller picture of the individual’s needs.

For someone who hasn’t responded to antidepressants, the team may consider TMS or ketamine. Another patient might be evaluated for neurofeedback as part of a broader treatment strategy. The decision depends on clinical suitability, not simply whether a particular brainwave pattern appears on the map.

This process involves several considerations:

  • Clinical symptoms. Understanding their severity and impact on everyday life
  • Treatment history. Reviewing medications and therapies already attempted
  • Brain mapping findings. Identifying electrical activity patterns that may warrant further consideration
  • Safety and suitability. Assessing medical conditions, contraindications and treatment requirements
  • Patient preferences. Discussing practical commitments, expectations and available alternatives

Rather than following a predetermined treatment pathway, qEEG-guided care uses assessment findings to support individualized clinical decisions.

Matching Brain Activity Patterns to Treatment Options

Brain mapping may help clinicians identify features worth investigating, but no single qEEG pattern reliably establishes which mental health treatment will work best. At Sun Health Center, the results contribute to discussions about three potential approaches.

Transcranial Magnetic Stimulation

Transcranial magnetic stimulation uses magnetic pulses to stimulate specific brain regions involved in mood regulation. It’s an established noninvasive treatment option for certain patients with depression.

Brain mapping may provide supplementary information about electrical activity that clinicians can consider when planning treatment. However, qEEG patterns alone don’t establish TMS eligibility or determine an optimal stimulation protocol.

Clinical history, diagnosis, safety screening and established treatment guidelines remain central to these decisions.

Research continues to examine how TMS treatment can be personalized. A 2025 study of 485 standard TMS treatment courses identified 40 extended treatment series among patients who hadn’t responded after 30 sessions. In 21 of those series, patients subsequently met response criteria.

Although the study didn’t evaluate qEEG-guided treatment selection, it highlights why treatment planning should account for individual responses rather than assume every patient follows the same course.

Neuro Therapy and Neurofeedback

Neurofeedback takes a different approach. It uses measurements of brain activity to provide feedback during training sessions. Patients typically complete exercises while sensors record electrical activity. Visual or auditory feedback helps them practice modifying certain patterns of brain activity.

An initial qEEG may help clinicians identify patterns to investigate when considering a neurofeedback protocol. It can also provide a baseline against which later recordings may be compared.

For example, clinicians may examine the distribution of brainwave frequencies when deciding which activity patterns to monitor during training. However, a difference on a brain map doesn’t necessarily indicate an abnormality requiring correction.

The evidence supporting neurofeedback varies considerably by condition and treatment approach.

At Sun Health Center, neurotherapy is one of several approaches that may be considered as part of an individualized care plan.

Ketamine Therapy

Ketamine may be considered for certain adults with treatment-resistant depression when conventional approaches haven’t provided sufficient relief. Its use for depression is considered off-label.

Unlike TMS, which uses magnetic stimulation, ketamine acts on brain signaling systems involving glutamate. Its effects can emerge more rapidly than those of many traditional antidepressants, although individual responses vary.

A qEEG assessment may contribute to the broader clinical picture, but there’s currently insufficient evidence to use brainwave patterns alone to determine who’ll benefit from ketamine.

At Sun Health Center, our clinicians evaluate symptoms, medical history, previous treatment experiences and safety considerations before recommending IV ketamine treatment.

This evaluation is particularly important because ketamine can temporarily increase blood pressure and cause dissociation or changes in perception. Medical monitoring is necessary during treatment.

Brain mapping therefore supports the overall assessment rather than serving as a stand-alone test for ketamine suitability.

Tracking Progress With Follow-Up Brain Maps

An initial assessment is the beginning of the process, not the final word on treatment. Someone receiving TMS may experience gradual improvement over several weeks, while another patient may show little change. Clinicians need to monitor these responses rather than assuming the original plan will remain appropriate.

When clinically appropriate, follow-up qEEG recordings can provide additional information about brain activity after treatment begins. Comparing recordings may reveal changes in measured electrical patterns, although these changes don’t necessarily correspond to improvements in symptoms.

Patient-reported experiences, clinical evaluations and established symptom measures remain essential for assessing treatment response. Follow-up maps should complement these measures rather than replace them.

A 2026 multinational TMS registry study analyzed 1,691 cases of standard repetitive TMS (rTMS) and reported a 43.6% response rate and a 28.7% remission rate. Greater treatment exposure was associated with higher odds of response, while lower initial depression severity was associated with remission.

These findings reinforce the importance of evaluating each patient’s progress rather than expecting identical outcomes.

If a patient isn’t improving as expected, our clinicians can review the treatment plan, discuss alternative approaches and determine whether further assessment is appropriate.

What qEEG Can and Can’t Tell You

A qEEG provides measurable information about electrical activity in the brain. It can help clinicians examine brainwave patterns, establish a baseline and consider findings alongside other assessment results.

However, qEEG can’t independently diagnose depression, anxiety, or other psychiatric conditions. It also can’t reliably predict whether a particular patient will respond to TMS, ketamine or neurofeedback.

This distinction matters because two patients with similar brainwave findings may have very different symptoms, medical histories and treatment needs.

Brain mapping is only one part of the decision-making process. Before recommending treatment, clinicians also need to understand how symptoms affect a patient’s everyday life.

Our clinicians also consider practical factors, including treatment availability, appointment schedules and whether a patient can safely complete the recommended therapy.

For example, TMS typically involves repeated outpatient appointments over several weeks. Ketamine requires supervised treatment sessions and arrangements for transportation afterward.

Patients should understand these commitments before beginning treatment. Shared decision-making allows them to discuss potential benefits, limitations and alternatives with their clinician.

Frequently Asked Questions

Does a qEEG Brain Map Diagnose Depression?

No. A qEEG measures electrical activity rather than diagnosing depression. Clinicians use psychiatric assessments, reported symptoms, medical history and established diagnostic criteria to evaluate mental health conditions. Learn more about whether a qEEG can diagnose a mental disorder.

Can Brain Mapping Tell Me Whether TMS or Ketamine Will Work?

Not reliably. Researchers are investigating whether brain activity patterns can help predict treatment response, but qEEG alone can’t determine which therapy will be effective. Clinical evaluation remains essential.

Will I Need Another Brain Map During Treatment?

Follow-up mapping may be considered when clinically appropriate, particularly when evaluating changes in brain activity. However, repeat qEEG testing isn’t necessary for every patient, and treatment progress is primarily assessed through symptoms and clinical response.

Start With a Personalized Assessment at Sun Health Center

Mental health treatment shouldn’t depend on assumptions about how someone with a particular diagnosis will respond. At Sun Health Center, qEEG brain mapping can be part of a comprehensive clinical evaluation that helps shape individualized care.

Whether TMS, ketamine or neurofeedback is appropriate depends on your symptoms, treatment history and medical needs. Contact Sun Health Center to learn more about our assessment process and available treatment options.

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Footer

Sun Health Center Logo
502 South Federal Highway
Deerfield Beach, FL 33441
contact@sunhealthcenter.com
855-459-0278

Book an Appointment
Privacy Policy
About Us

© 2026 Sun Health Center All Rights Reserved

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

Book Now

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
What services are you interested in?*

Subscribe to Our Posts